• SPX
  • $5,738.17
  • -0.13 %
  • -$7.20
  • DJI
  • $42,313.00
  • 0.33 %
  • $137.89
  • N225
  • $39,829.56
  • 2.32 %
  • $903.93
  • FTSE
  • $8,320.76
  • 0.43 %
  • $35.85
  • IXIC
  • $18,119.59
  • -0.39 %
  • -$70.70
Akero Therapeutics, Inc. (AKRO) Insider Traders

Akero Therapeutics, Inc. (AKRO) Insider Traders

NASDAQ Currency in USD Disclaimer

Stock Price

$28.25

-$1.09

(-3.72%)

Day's range
$28.17
Day's range
$29.87
  • NUMBER OF INSIDER BUYING

    (Last 12 Months)

    1
  • NUMBER OF INSIDER SELLING

    (Last 12 Months)

    6
  • AMOUNT OF INSIDERS BUYING

    (Last 12 Months)

    $2.68 M
  • AMOUNT OF INSIDERS SELLING

    (Last 12 Months)

    $14.25 M

Akero Therapeutics, Inc. Insider Transactions

Akero Therapeutics, Inc. Insider Trades History

Insider Name Buy/Sell Shares Bought/Sold
@ Price
Total Transaction Shares Held
After Transaction
Transaction Date Filing Date Details
Yale Catriona

Chief Development Officer

Sell 5,500 @ $27.65 $152,086 75,294 09/20/2024 09/23/2024
Yale Catriona

Chief Development Officer

Sell 3,871 @ $27.56 $106,685 75,294 09/18/2024 09/18/2024
Yale Catriona

Chief Development Officer

Sell 2,037 @ $27.55 $56,115 75,294 09/17/2024 09/18/2024
Yale Catriona

Chief Development Officer

Sell 2,485 @ $27.52 $68,375 75,294 09/16/2024 09/18/2024
Sell 568 @ $26.18 $14,870 236,286 09/10/2024 09/13/2024
Yale Catriona

Chief Development Officer

Sell 637 @ $26.18 $16,677 75,294 09/10/2024 09/13/2024
Sell 639 @ $26.18 $16,729 41,152 09/10/2024 09/13/2024
Rolph Timothy

Chief Scientific Officer

Sell 537 @ $26.18 $14,059 180,705 09/10/2024 09/13/2024
Sell 1,738 @ $26.18 $45,501 605,417 09/10/2024 09/13/2024
Sell 3,710 @ $26.42 $98,014 238,144 09/03/2024 09/05/2024
Sell 1,290 @ $27.58 $35,573 236,854 09/03/2024 09/05/2024
Yale Catriona

Chief Development Officer

Sell 949 @ $27.61 $26,206 75,931 09/03/2024 09/05/2024
Sell 23,175 @ $26.41 $612,098 41,791 08/27/2024 08/29/2024
Sell 18,116 @ $27.21 $492,954 41,791 08/26/2024 08/29/2024
Yale Catriona

Chief Development Officer

Sell 5,200 @ $27.51 $143,073 75,931 08/26/2024 08/28/2024
Yale Catriona

Chief Development Officer

Sell 8,851 @ $27.53 $243,641 75,931 08/23/2024 08/28/2024
Sell 3,031 @ $26.44 $80,140 243,823 08/01/2024 08/02/2024
Sell 1,969 @ $27.23 $53,616 241,854 08/01/2024 08/02/2024
Sell 1,791 @ $27.00 $48,357 62,272 07/25/2024 07/25/2024
Sell 20,481 @ $27.66 $566,463 41,791 07/25/2024 07/25/2024

Akero Therapeutics, Inc. Frequently Asked Questions

  • Who is on Akero Therapeutics, Inc.'s Insider Roster?

    The list of insiders at Akero Therapeutics, Inc. includes Young Jonathan, Cheng Andrew, Graham G. Walmsley, Rolph Timothy, White William Richard, Yale Catriona, Lamy Patrick.

  • How much insider selling is happening at Akero Therapeutics, Inc.?

    Insiders have sold a total of 512,091 Akero Therapeutics, Inc. shares in the last 12 months for a total of 14.25 M sold.

  • Which Akero Therapeutics, Inc. insiders have been selling company stock?

    The following insiders have sold Akero Therapeutics, Inc. shares in the last 12 months: Young Jonathan ($1.40 M), Cheng Andrew ($4.52 M), Rolph Timothy ($96,151), White William Richard ($6.58 M), Yale Catriona ($1.64 M), Lamy Patrick ($12,883),

  • How much insider buying is happening at Akero Therapeutics, Inc.?

    Insiders have purchased a total of 150,000 Akero Therapeutics, Inc. shares in the last 12 months for a total of 2.68 M sold.

  • Which Akero Therapeutics, Inc. insiders have been buying company stock?

    The following insiders have purchased Akero Therapeutics, Inc. shares in the last 12 months: Graham G. Walmsley ($2.68 M),

×
New Alert

Select an alert type

Choose sentiment spike or mentions spike or both to receive email alerts and app notification for the selected stock.
Note: Please be aware that you will receive an email only once a day, around 8:00 AM (EST), in the event of any spike.
In future if you don't want to receive any email then delete stocks added into alert section.

New Alert

Setup alert

×

Premium Content

This content is only available for premium members. Please become a paid member to access.

Download App

Currently, memberships can only be purchased through the app.

×

Log In


or

download app using google store Continue with Google download app using apple Continue with Apple

Email Verification

An email with a verification code has been sent to your email address.

Welcome to StockNews!

Create Your Account

Email Verification

An email with a verification code has been sent to your email address.